Back to Search
Start Over
Cytokine engineered NK-92 therapy to improve persistence and anti-tumor activity
- Source :
- Theranostics. 13:1506-1519
- Publication Year :
- 2023
- Publisher :
- Ivyspring International Publisher, 2023.
Details
- ISSN :
- 18387640
- Volume :
- 13
- Database :
- OpenAIRE
- Journal :
- Theranostics
- Accession number :
- edsair.doi...........c0398344de9f40b337c3a356a8f56b4b
- Full Text :
- https://doi.org/10.7150/thno.79942